Effect of 5-HT3 antagonists and a 5-HT(1A) agonist on fluoxetine-induced conditioned gaping reactions in rats

Cheryl L Limebeer1, Devin E Litt, Linda A Parker

  • 1Department of Psychology, University of Guelph, Guelph, Ontario, Canada, N1H 2W1.

Psychopharmacology
|December 17, 2008
PubMed
Abstract

Insights

Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine can cause nausea, modeled as conditioned gaping in rats. 5-HT(1A) agonists, but not 5-HT(3) antagonists, reversed this effect, suggesting novel therapeutic targets.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • The serotonin (5-HT) system plays a crucial role in regulating nausea and vomiting.
  • Selective serotonin reuptake inhibitors (SSRIs) are known to induce nausea in clinical settings.
  • Conditioned gaping in rats is a validated animal model for nausea.

Purpose of the Study:

  • To investigate the ability of fluoxetine, a SSRI, to induce conditioned gaping in rats.
  • To evaluate the efficacy of 5-HT(3) antagonists (ondansetron, palonosetron) and a 5-HT(1A) autoreceptor agonist (8-OH-DPAT) in reversing fluoxetine-induced conditioned gaping.
  • To compare the effects of these antagonists on conditioned gaping induced by fluoxetine versus lithium chloride (LiCl).

Main Methods:

  • Rats received pairings of sucrose solution and varying doses of fluoxetine.
  • Conditioned gaping was assessed after drug-free test trials.
  • Antagonists (ondansetron, palonosetron) or agonist (8-OH-DPAT) were administered before conditioning trials.
  • Comparisons were made between fluoxetine-induced and LiCl-induced conditioned gaping.

Main Results:

  • Fluoxetine (20 mg/kg) successfully induced conditioned gaping in rats.
  • Pretreatment with 8-OH-DPAT prevented fluoxetine-induced conditioned gaping.
  • 5-HT(3) antagonists did not reverse fluoxetine-induced conditioned gaping.
  • Palonosetron attenuated LiCl-induced conditioned gaping.

Conclusions:

  • Conditioned nausea induced by SSRIs may be refractory to 5-HT(3) antagonists.
  • 5-HT(1A) autoreceptor agonists show potential in reversing SSRI-induced nausea.
  • These findings highlight differential mechanisms underlying nausea induced by different agents.

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...